{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:42:20Z","timestamp":1768873340386,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Pharma SAS, Rueil-Malmaison, France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00417-017-3685-y","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T09:32:48Z","timestamp":1494408768000},"page":"1651-1660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France"],"prefix":"10.1007","volume":"255","author":[{"given":"G\u00e9rard","family":"Mimoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Ebran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Typhaine","family":"Grenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Donati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salomon-Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ponthieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,10]]},"reference":[{"key":"3685_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/jmg.2004.030171","volume":"42","author":"N Chassaing","year":"2005","unstructured":"Chassaing N, Martin L, Calvas P, Le Bert M, Hovnanian A (2005) Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 42:881\u2013892. doi:\n10.1136\/jmg.2004.030171","journal-title":"J Med Genet"},{"key":"3685_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","volume":"54","author":"RP Finger","year":"2009","unstructured":"Finger RP, Charbel Issa P, Ladewig MS, Gotting C, Szliska C, Scholl HP, Holz FG (2009) Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 54:272\u2013285. doi:\n10.1016\/j.survophthal.2008.12.006","journal-title":"Surv Ophthalmol"},{"key":"3685_CR3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/21678707.2014.908702","volume":"2","author":"J Uitto","year":"2014","unstructured":"Uitto J, Jiang Q, Varadi A, Bercovitch LG, Terry SF (2014) Pseudoxanthoma Elasticum: diagnostic features, classification, and treatment options. Expert Opin Orphan Drugs 2:567\u2013577","journal-title":"Expert Opin Orphan Drugs"},{"key":"3685_CR4","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jaad.2004.01.015","volume":"51","author":"L Bercovitch","year":"2004","unstructured":"Bercovitch L, Terry P (2004) Pseudoxanthoma elasticum 2004. J Am Acad Dermatol 51:S13\u2013S14. doi:\n10.1016\/j.jaad.2004.01.015","journal-title":"J Am Acad Dermatol"},{"key":"3685_CR5","unstructured":"Gass JD (1997) Angioid streaks. In. Stereoscopic Atlas of Macular Diseases St Louis: Mosby: 118\u2013125"},{"key":"3685_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006982-200310000-00029","volume":"23","author":"JD Gass","year":"2003","unstructured":"Gass JD (2003) \u201ccomet\u201d lesion: an ocular sign of pseudoxanthoma elasticum. Retina 23:729\u2013730","journal-title":"Retina"},{"key":"3685_CR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(61)90078-X","volume":"30","author":"PJ Connor Jr","year":"1961","unstructured":"Connor PJ Jr, Juergens JL, Perry HO, Hollenhorst RW, Edwards JE (1961) Pseudoxanthoma elasticum and angioid streaks. A review of 106 cases. Am J Med 30:537\u2013543","journal-title":"Am J Med"},{"key":"3685_CR8","first-page":"111","volume":"38","author":"M Baccarani-Contri","year":"1994","unstructured":"Baccarani-Contri M, Vincenzi D, Cicchetti F, Mori G, Pasquali-Ronchetti I (1994) Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients. Eur J Histochem: EJH 38:111\u2013123","journal-title":"Eur J Histochem: EJH"},{"key":"3685_CR9","first-page":"81","volume":"5","author":"I Georgalas","year":"2009","unstructured":"Georgalas I, Papaconstantinou D, Koutsandrea C, Kalantzis G, Karagiannis D, Georgopoulos G, Ladas I (2009) Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag 5:81\u201389","journal-title":"Ther Clin Risk Manag"},{"key":"3685_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(82)90158-8","volume":"26","author":"JG Clarkson","year":"1982","unstructured":"Clarkson JG, Altman RD (1982) Angioid streaks. Surv Ophthalmol 26:235\u2013246","journal-title":"Surv Ophthalmol"},{"key":"3685_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000309915","volume":"197","author":"AM Mansour","year":"1988","unstructured":"Mansour AM, Shields JA, Annesley WH Jr, El-Baba F, Tasman W, Tomer TL (1988) Macular degeneration in angioid streaks. Ophthalmol J Int Ophtalmol Int J Ophthalmol Zeitschrift Augenheilkund 197:36\u201341","journal-title":"Ophthalmol J Int Ophtalmol Int J Ophthalmol Zeitschrift Augenheilkund"},{"key":"3685_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/IAE.0b013e3181c596b1","volume":"30","author":"JS Myung","year":"2010","unstructured":"Myung JS, Bhatnagar P, Spaide RF, Klancnik JM Jr, Cooney MJ, Yannuzzi LA, Freund KB (2010) Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 30:748\u2013755. doi:\n10.1097\/IAE.0b013e3181c596b1","journal-title":"Retina"},{"key":"3685_CR13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9394(14)71398-4","volume":"116","author":"JI Lim","year":"1993","unstructured":"Lim JI, Bressler NM, Marsh MJ, Bressler SB (1993) Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 116:414\u2013423","journal-title":"Am J Ophthalmol"},{"key":"3685_CR14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006982-199701000-00003","volume":"17","author":"A Pece","year":"1997","unstructured":"Pece A, Avanza P, Galli L, Brancato R (1997) Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina 17:12\u201316","journal-title":"Retina"},{"key":"3685_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ophtha.2005.02.011","volume":"112","author":"AC Browning","year":"2005","unstructured":"Browning AC, Chung AK, Ghanchi F, Harding SP, Musadiq M, Talks SJ, Yang YC, Amoaku WM, United Kingdom PDTUG (2005) Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 112:1227\u20131231. doi:\n10.1016\/j.ophtha.2005.02.011","journal-title":"Ophthalmology"},{"key":"3685_CR16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00006982-200410000-00020","volume":"24","author":"C Aras","year":"2004","unstructured":"Aras C, Baserer T, Yolar M, Yetik H, Artunay O, Guzel H, Ozkan S (2004) Two cases of choroidal neovascularization treated with transpupillary thermotherapy in angioid streaks. Retina 24:801\u2013803","journal-title":"Retina"},{"key":"3685_CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9394(00)00809-6","volume":"131","author":"DB Roth","year":"2001","unstructured":"Roth DB, Estafanous M, Lewis H (2001) Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am J Ophthalmol 131:390\u2013392","journal-title":"Am J Ophthalmol"},{"key":"3685_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00006982-199515030-00003","volume":"15","author":"DA Adelberg","year":"1995","unstructured":"Adelberg DA, Del Priore LV, Kaplan HJ (1995) Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 15:198\u2013205","journal-title":"Retina"},{"key":"3685_CR19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431. doi:\n10.1056\/NEJMoa054481","journal-title":"N Engl J Med"},{"key":"3685_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, Group AS (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57\u201365 e55. doi:\n10.1016\/j.ophtha.2008.10.018","journal-title":"Ophthalmology"},{"key":"3685_CR21","unstructured":"AVASTIN Prescribing Information. \nhttp:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/125085s0169lbl.pdf\n\n. accessed 12 Feb 2016"},{"key":"3685_CR22","unstructured":"Lucentis\u00ae Summary of Product Characteristics. Basel, Switzerland: Novartis AG; 2013. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR__Product_Information\/human\/000715\/WC500043546.pdf\n\n. accessed 12 Feb 2016"},{"key":"3685_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/IAE.0b013e31809ff5df","volume":"27","author":"P Bhatnagar","year":"2007","unstructured":"Bhatnagar P, Freund KB, Spaide RF, Klancnik JM Jr, Cooney MJ, Ho I, Fine HF, Yannuzzi LA (2007) Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 27:897\u2013902. doi:\n10.1097\/IAE.0b013e31809ff5df","journal-title":"Retina"},{"key":"3685_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ajo.2011.03.022","volume":"152","author":"RP Finger","year":"2011","unstructured":"Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG (2011) Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study. Am J Ophthalmol 152:695\u2013703. doi:\n10.1016\/j.ajo.2011.03.022","journal-title":"Am J Ophthalmol"},{"key":"3685_CR25","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/IAE.0b013e3181d2f11d","volume":"30","author":"ID Ladas","year":"2010","unstructured":"Ladas ID, Kotsolis AI, Ladas DS, Niskopoulou M, Georgalas I, Papakonstantinou D, Rouvas AA (2010) Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Retina 30:1185\u20131189. doi:\n10.1097\/IAE.0b013e3181d2f11d","journal-title":"Retina"},{"key":"3685_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ajo.2010.06.004","volume":"150","author":"G Mimoun","year":"2010","unstructured":"Mimoun G, Tilleul J, Leys A, Coscas G, Soubrane G, Souied EH (2010) Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. Am J Ophthalmol 150:692\u2013700 e691. doi:\n10.1016\/j.ajo.2010.06.004","journal-title":"Am J Ophthalmol"},{"key":"3685_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/eye.2012.116","volume":"26","author":"M Shah","year":"2012","unstructured":"Shah M, Amoaku WM (2012) Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks. Eye 26:1194\u20131198. doi:\n10.1038\/eye.2012.116","journal-title":"Eye"},{"key":"3685_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/IAE.0b013e3181cafc75","volume":"30","author":"M Vadala","year":"2010","unstructured":"Vadala M, Pece A, Cipolla S, Monteleone C, Ricci F, Boscia F, Cillino S (2010) Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab. Retina 30:903\u2013907. doi:\n10.1097\/IAE.0b013e3181cafc75","journal-title":"Retina"},{"key":"3685_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/IAE.0000000000000745","volume":"36","author":"J Tilleul","year":"2015","unstructured":"Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, Srour M, Souied EH (2015) Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: four-year follow-up. Retina 36:483\u2013491. doi:\n10.1097\/IAE.0000000000000745","journal-title":"Retina"},{"key":"3685_CR30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/IAE.0b013e31816d81d0","volume":"28","author":"L Derriman","year":"2008","unstructured":"Derriman L, Marshall J, Moorman C, Downes SM (2008) The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs). Retina 28:910; author reply 910-911. doi:\n10.1097\/IAE.0b013e31816d81d0","journal-title":"Retina"},{"key":"3685_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/IAE.0b013e318207d1dc","volume":"31","author":"RP Finger","year":"2011","unstructured":"Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN (2011) Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina 31:1268\u20131278. doi:\n10.1097\/IAE.0b013e318207d1dc","journal-title":"Retina"},{"key":"3685_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/1752-1947-8-458","volume":"8","author":"MC Savastano","year":"2014","unstructured":"Savastano MC, Minnella AM, Zinzanella G, Falsini B, Caporossi A (2014) Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report. J Med Case Rep 8:458. doi:\n10.1186\/1752-1947-8-458","journal-title":"J Med Case Rep"},{"key":"3685_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/08820538.2012.680644","volume":"27","author":"N Zebardast","year":"2012","unstructured":"Zebardast N, Adelman RA (2012) Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up. Semin Ophthalmol 27:61\u201364. doi:\n10.3109\/08820538.2012.680644","journal-title":"Semin Ophthalmol"},{"key":"3685_CR34","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archopht.125.10.1422","volume":"125","author":"M Rinaldi","year":"2007","unstructured":"Rinaldi M, Dell\u2019Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C (2007) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125:1422\u20131423. doi:\n10.1001\/archopht.125.10.1422","journal-title":"Arch Ophthalmol"},{"key":"3685_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40942-015-0011-x","volume":"1","author":"CB Orly Gal-Or","year":"2015","unstructured":"Orly Gal-Or CB, Bailey Freund K (2015) Optical coherence tomography angiography findings of choroidal neovascularization in pseudoxanthoma elasticum. Int J Retin Vitr 1:11","journal-title":"Int J Retin Vitr"},{"key":"3685_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajo.2010.04.011","volume":"150","author":"P Abraham","year":"2010","unstructured":"Abraham P, Yue H, Wilson L (2010) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2. Am J Ophthalmol 150:315\u2013324 e311. doi:\n10.1016\/j.ajo.2010.04.011","journal-title":"Am J Ophthalmol"},{"key":"3685_CR37","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ophtha.2009.05.024","volume":"116","author":"DS Boyer","year":"2009","unstructured":"Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG (2009) A phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 116:1731\u20131739. doi:\n10.1016\/j.ophtha.2009.05.024","journal-title":"Ophthalmology"},{"key":"3685_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","volume":"148","author":"GA Lalwani","year":"2009","unstructured":"Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M (2009) A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study. Am J Ophthalmol 148:43\u201358 e41. doi:\n10.1016\/j.ajo.2009.01.024","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3685-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T05:24:23Z","timestamp":1501651463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3685-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,10]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3685"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3685-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,10]]}}}